ConductScience.org, home

Gene · 2213

FCGR2B: Fc gamma receptor IIb

11 sourcesgene-search-2026-11-11-0.1.0

Download JSON
Cite this record

ConductScience Library. FCGR2B: Fc gamma receptor IIb. Genes, record 2213. Release gene-search-2026-11-11-0.1.0, 11 Nov 2026. https://conductscience.org/library/genes/2213

On this page

Gene

Its symbol and name are HGNC's, unless HGNC and NCBI Gene contradict each other.

Symbol
FCGR2B
HGNC
Name
Fc gamma receptor IIb
HGNC
NCBI Gene ID
2213
NCBI Gene
HGNC ID
HGNC:3618
HGNC
Ensembl
ENSG00000072694
NCBI Gene
Aliases
CD32, CD32B, FCG2, FCGR2, FcGRIIB, FcgammaRIIb, IGFR2
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
P31994Low affinity immunoglobulin gamma Fc region receptor II-b3105Ensembl, GeneID, HGNC

Source UniProt

Patents145

Patents whose sequence listing holds the protein exactly: the same sequence, by SHA-256, length and CRC-64. A sequence a patent lists is not always one it claims.

PublicationPublishedSEQ ID NOProteinSource
EP 4755449 A22026-06-10213P31994Espacenet
EP 4755450 A22026-06-10213P31994Espacenet
EP 4755457 A22026-06-10169P31994Espacenet
JP 2026004568 A2026-01-1446101P31994Espacenet
JP 2026004568 A2026-01-1446104P31994Espacenet
JP 2026001164 A2026-01-06213P31994Espacenet
JP 2025169385 A2025-11-12213P31994Espacenet
US 12415857 B22025-09-16169P31994Espacenet
JP 2025529142 A2025-09-041551P31994Espacenet
US 12371689 B22025-07-291551P31994Espacenet

1 to 10 of 145

See all 145 patents

Drugs1

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismAction
OBEXELIMABCHEMBL4298134Low affinity immunoglobulin gamma Fc region receptor II-b inhibitorINHIBITOR

Source ChEMBL

Trials5

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

TrialDrugPhaseResults first postedSource
NCT06564311OBEXELIMABPHASE2ClinicalTrials.gov
NCT06559163OBEXELIMABPHASE2ClinicalTrials.gov
NCT05786573OBEXELIMABPHASE3ClinicalTrials.gov
NCT02725515OBEXELIMABPHASE22019-08-09ClinicalTrials.gov
NCT02725476OBEXELIMABPHASE22018-12-07ClinicalTrials.gov

NIH grants2,625

NIH projects whose papers are about the gene, through NIH's grant-paper links.

ProjectTitleIts papers about the geneNewest fiscal year
P30CA008748Cancer Center Support Grant282025
R35CA196620Molecular mechanisms of antibody-mediated immunotherapies162025
UL1TR001866Developing, Demonstrating, and Disseminating Innovative Programs to Achieve Translational Success132025
P30CA016058Cancer Center Support Grant102025
P30CA016672Cancer Center Support Grant102025
P51OD011132Emory National Primate Research Center102025
ZIAAI001064Malaria immunology102025
T32AI070081Advanced Research Training in Transplantation Science92025
U19AI135995Center for Viral Systems Biology (CViSB)92025
P30AI027767UAB Center for AIDS Research (CFAR)82025

1 to 10 of 2,625Source NIH's project files

See all 2,625 nih grants

Papers4,232

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

PMIDFound bySource
42826900PubTator, text miningPubMed
42818132PubTator, text miningPubMed
42812615PubTator, text miningPubMed
42806388PubTator, text miningPubMed
42805593PubTator, text miningPubMed
42805482PubTator, text miningPubMed
42759329PubTator, text miningPubMed
42652215PubTator, text miningPubMed
42614358PubTator, text miningPubMed
42575345PubTator, text miningPubMed

1 to 10 of 4,232

See all 4,232 papers

Sources 11

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNone stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GeneNone named. Public domain as US government information
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/2213

GET https://conductscience.org/api/genes/v1/2213/patents?page=2